Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-07

Study Completion Date

2020-03-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the study is to evaluate the effectiveness of additional risk minimization measures material by assessing the knowledge and understanding of healthcare professionals regarding the key safety messages provided in the material.

The secondary objective of the study is to evaluate if healthcare professionals know Dengvaxia product information, namely, age indication and contraindications.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

NCT02948933

Dengue Fever Dengue Hemorrhagic Fever

COMPLETED

Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India

NCT01550289

Dengue Dengue Fever Dengue Hemorrhagic Fever

COMPLETED PHASE2

Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil

NCT03960385

Dengue

COMPLETED

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults

NCT00270699

Dengue Fever

COMPLETED PHASE1

Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease

NCT01502735

Dengue Fever

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a cross-sectional Survey. Study data are collected through a questionnaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dengue Virus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prescribers of Dengvaxia

Healthcare professionals who are current or past prescribers of Dengvaxia

No intervention

Intervention Type OTHER

Questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Healthcare professionals who are current or past prescribers of Dengvaxia

Exclusion Criteria

* Healthcare professionals who have never prescribed Dengvaxia
* Healthcare professionals who may have a conflict of interest with the survey (i.e. Healthcare professionals employed by regulatory bodies, pharmaceutical industries)
* Healthcare professionales who have participated in testing the questionnaire for comprehensibility, consistency and the appropriateness of medical terms

The above information is not intended to contain all considerations relevant to participation in the survey.

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes